Potentiation of fusidic acid and lentinan effects upon normal and transformed fibroblastic cells by amphotericin B.
D000666:Amphotericin B / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002247:Carbon Isotopes; D002470:Cell Survival; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004357:Drug Synergism; D005347:Fibroblasts / Q000187:drug effects; D005672:Fusidic Acid / Q000494:pharmacology*; D066298:In Vitro Techniques; D007930:Leucine / Q000037:antagonists & inhibitors / Q000378:metabolism; D008168:Lung / Q000187:drug effects; D008854:Microscopy, Electron; D010649:Phenylalanine / Q000378:metabolism; D011134:Polysaccharides / Q000494:pharmacology*; D014176:Protein Biosynthesis; D051381:Rats; D014316:Tritium; D014498:Uracil / Q000037:antagonists & inhibitors / Q000378:metabolism
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D011134:Polysaccharides; D014316:Tritium; D003609:Dactinomycin; D010649:Phenylalanine; D014498:Uracil; D005672:Fusidic Acid; D000666:Amphotericin B; D003513:Cycloheximide; D007930:Leucine